The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis

OBJECTIVE: Pirfenidone (PFD) is often used for years, but the efficacy and safety of long-term PFD therapy in patients with idiopathic pulmonary fibrosis (IPF) are not fully understood. METHODS AND PATIENTS: We retrospectively evaluated 46 patients with IPF who received PFD between February 2009 and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intern Med
Päätekijät: Ogawa, Kazumasa, Miyamoto, Atsushi, Hanada, Shigeo, Takahashi, Yui, Murase, Kyoko, Mochizuki, Sayaka, Uruga, Hironori, Takaya, Hisashi, Morokawa, Nasa, Kishi, Kazuma
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society of Internal Medicine 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207833/
https://ncbi.nlm.nih.gov/pubmed/29780123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0559-17
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia